Anika Therapeutics Inc ANIK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/04/21 EST
38.13UNCH (UNCH)
Volume
1,699
Close
38.13quote price arrow down-0.57 (-1.47%)
Volume
148,138
52 week range
22.01 - 47.48

...

Loading . . .

KEY STATS

  • Open38.82
  • Day High39.57
  • Day Low37.92
  • Prev Close38.13
  • 52 Week High47.48
  • 52 Week High Date12/18/20
  • 52 Week Low22.01
  • 52 Week Low Date03/19/20
  • Market Cap541.83M
  • Shares Out14.21M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta1.23
  • 1 Year % Change-11.45

RATIOS/PROFITABILITY

  • EPS (TTM)-1.69
  • P/E (TTM)-22.55
  • Fwd P/E (NTM)200.68
  • EBITDA (MRQ)7.896M
  • ROE (MRQ)-1.51%
  • Revenue (MRQ)127.54M
  • Gross Margin (MRQ)57.55%
  • Net Margin (MRQ)-3.35%
  • Debt To Equity (MRQ)8.85%

EVENTS

  • Earnings Date03/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Anika Therapeutics Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Anika Therapeutics, Inc. is a joint preservation company. The Company creates and delivers advancements in early intervention orthopedic care. It partners with physicians and develops minimally invasive products. It focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. Its product categories include joint pain management therapies, orthopedic joint preservation and restoration care...
Cheryl Blanchard Ph.D.
President
Michael Levitz
Chief Financial Officer
Thomas Finnerty
Executive Vice President
James Loerop
Executive Vice President
David Colleran J.D.
Executive Vice President
Address
32 Wiggins Ave
Bedford, MA
01730-2315
United States